Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Yoichi Kobayashi"'
Autor:
Shoichi Maruyama, Shinko Hayashi, Teiji Wada, Daisuke Sugiyama, Michinori Kadokura, Atsushi Tanemura, Kazuki Hirahara, Masato Amano, Ichiro Watanabe, Shiho Kozuma, Megumi Miyamoto, Kenichi Wakita, Atsushi Okamoto, Masato Hata, Kazuki Satoh, Takahiko Sato, Saori Ishida, Hiroyoshi Nishikawa, Helmut Jonuleit, Toshinori Agatsuma, Yoichi Kobayashi, Andrea Tuettenberg, Kyungtaek Lim, Kaori Fujimaki
Publikováno v:
International Immunology. 33:435-446
Regulatory T (Treg) cells, which are essential for maintaining self-tolerance, inhibit anti-tumor immunity, consequently hindering protective cancer immunosurveillance, and hampering effective anti-tumor immune responses in tumor-bearing hosts. Here,
Publikováno v:
Human Cell. 34:394-399
Dienogest (DNG), is an effective and widely used progestin used in the treatment of endometriosis, yet clinically, a subset of cases show resistance to DNG treatment. During a previous investigation on the effect of DNG of cytokines and growth factor
Autor:
Tsutomu Yanagisawa, Naho Kagiyama, Kazuyoshi Kurashima, Kenji Takano, Takashi Nishida, Eriko Kawate, Taisuke Isono, Yoichi Kobayashi, Youtaro Takaku, Noboru Takayanagi, Chiaki Hosoda, Takashi Ishiguro
Publikováno v:
Thoracic Cancer
Background Non‐small cell lung cancer (NSCLC) patients with pre‐existing respiratory diseases have been excluded in clinical trials of immune checkpoint inhibitor (ICI) therapy, and it is unknown whether the same degree of response can be expecte
Autor:
Kei Tanaka, Kazuhiko Nakabayashi, Tomoko Kawai, Kenji Matsumoto, Shinji Tanigaki, Yoichi Kobayashi, Kenichiro Hata
Publikováno v:
Human Cell. 33:37-46
Pregnant women with increased insulin resistance, characterized by elevated levels of tumor necrosis factor-alpha (TNF-α) and insulin-like growth factor-I (IGF-I), are at high risk of preeclampsia. We hypothesized that TNF-α and IGF-I affect the pl
Autor:
Tsutomu Yanagisawa, Yuma Matsui, Kazuyoshi Kurashima, Hitomi Nakajima, Noboru Takayanagi, Yotaro Takaku, Chiaki Hosoda, Yoichi Kobayashi, Shun Shibata, Taisuke Isono, Kenji Takano, Takashi Nishida, Eriko Kawate, Naho Kagiyama, Takashi Ishiguro
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 9, Pp 1387-1397 (2021)
Thoracic Cancer, Vol 12, Iss 9, Pp 1387-1397 (2021)
Background Although clinical trials have investigated the addition of pembrolizumab to chemotherapy for non‐small cell lung cancer, none have investigated the addition of chemotherapy to pembrolizumab. Methods We conducted a retrospective study of
Autor:
Masae Ikeda, Akiko Ohno, Hidetaka Katabuchi, Satoru Nagase, Isao Murakami, Yoichi Kobayashi, Hiroshi Yamashita, Masatoshi Yokoyama, Takayuki Enomoto, Mikio Mikami
Publikováno v:
Heliyon
Heliyon, Vol 6, Iss 10, Pp e05193-(2020)
Heliyon, Vol 6, Iss 10, Pp e05193-(2020)
Objective With increased screening, more patients with precancerous or early cervical cancer are now being identified. Age at pregnancy, and thus number of patients requiring fertility preservation, have also increased, resulting in more diagnostic a
Autor:
Momoe Watanabe, Yukiko Matsuzawa, Takashi Nagashima, Yoichi Kobayashi, Kei Tanaka, Mitsutoshi Iwashita, Tomoko Izawa, Miho Matsushima
Publikováno v:
Growth Hormone & IGF Research. 41:34-41
Objective Trophoblast survival is regulated by cytokines and growth factors. While the pharmacological levels (10–100 ng/mL) of tumor necrosis factor (TNF)- α affect trophoblasts survival in vitro, the effects of the physiological levels (1–10 p
Autor:
Taichiro Goto, Toshio Oyama, Masao Omata, Yoichi Kobayashi, Yoshinori Uchida, Kenji Amemiya, Toshiharu Tsutsui, Hitoshi Mochizuki, Takahiro Nakagomi, Yoshihiro Miyashita, Yoshihiko Ooka, Yuki Iijima, Yumiko Kakizaki, Yosuke Hirotsu
Publikováno v:
European Journal of Cancer. 86:349-357
Introduction Immunotherapy has become a treatment option for lung cancer. The utility of nivolumab as second-line treatment for non–small cell lung cancer has been proven, but predictive biomarkers influencing its efficacy remain unknown. Methods T
Autor:
Mitsutoshi Iwashita, Hironori Matsumoto, Hiromi Shibuya, Satoshi Umezawa, Kei Dozono, Momoe Watanabe, Kiyoshi Takamatsu, Juri Sugiyama, Yoichi Kobayashi, Tatsuo Yamazaki, Mai Momomura, Yoshiko Nishigaya, Kei Tanaka
Publikováno v:
International Journal of Clinical Oncology. 22:533-540
Prognostic clinicopathological factors for type 1 endometrial cancer are unknown and the purpose of the current study was to determine the independent prognostic variables for type 1 endometrial cancer. We performed a retrospective study of 168 patie
Autor:
Yoshiko Nishigaya, Hiromi Shibuya, Momoe Watanabe, Hironori Matsumoto, Yoichi Kobayashi, Mitsutoshi Iwashita
Publikováno v:
JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY. 33:63-68